-
-
-
-
-
-
-
Corcept Therapeutics (CORT) PT Lowered to $99 at Canaccord Genuity
-
-
-
-
-
-
-
Corcept submits European application for ovarian cancer treatment
-
-
-
-
-
-
-
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Corcept Therapeutics (CORT) Names Robert S. Fishman as CMO
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

